Inês Graça

1.0k total citations
26 papers, 804 citations indexed

About

Inês Graça is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Inês Graça has authored 26 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Inês Graça's work include Epigenetics and DNA Methylation (14 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (6 papers). Inês Graça is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (6 papers). Inês Graça collaborates with scholars based in Portugal, United Kingdom and Spain. Inês Graça's co-authors include Cármen Jerónimo, Rui Henrique, Elsa Sousa, Joäo Carvalho, Filipa Quintela Vieira, Jorge Oliveira, Pedro Costa‐Pinheiro, Tiago Baptista, Sara Monteiro‐Reis and Carlos Palmeira and has published in prestigious journals such as PLoS ONE, Gene and Cancer Letters.

In The Last Decade

Inês Graça

23 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inês Graça Portugal 16 604 253 167 87 80 26 804
Yongping Cui China 20 640 1.1× 191 0.8× 89 0.5× 235 2.7× 44 0.6× 42 891
Paola Sanese Italy 11 423 0.7× 127 0.5× 143 0.9× 101 1.2× 21 0.3× 32 583
Yan-qing Ding China 18 456 0.8× 172 0.7× 52 0.3× 188 2.2× 51 0.6× 71 747
Yeyang Xu China 10 523 0.9× 397 1.6× 79 0.5× 107 1.2× 25 0.3× 17 710
Yadong Sun China 13 412 0.7× 261 1.0× 221 1.3× 95 1.1× 12 0.1× 27 668
Chaoxia Zou China 16 673 1.1× 520 2.1× 65 0.4× 127 1.5× 14 0.2× 35 926
Can Tan United States 9 492 0.8× 70 0.3× 40 0.2× 102 1.2× 61 0.8× 22 715

Countries citing papers authored by Inês Graça

Since Specialization
Citations

This map shows the geographic impact of Inês Graça's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inês Graça with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inês Graça more than expected).

Fields of papers citing papers by Inês Graça

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inês Graça. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inês Graça. The network helps show where Inês Graça may publish in the future.

Co-authorship network of co-authors of Inês Graça

This figure shows the co-authorship network connecting the top 25 collaborators of Inês Graça. A scholar is included among the top collaborators of Inês Graça based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inês Graça. Inês Graça is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graça, Inês, João A. Rodrigues, José C. Martins, et al.. (2025). Exploring In Vitro Mesenchymal Stem Cell Osteodifferentiation via Vibrational Microspectroscopy: A Review. Stem Cell Reviews and Reports. 21(7). 2043–2065.
2.
Graça, Inês, Catarina S. H. Jesus, Iola F. Duarte, et al.. (2025). Metabolic markers detect early ostedifferentiation of mesenchymal stem cells from multiple donors. Stem Cell Research & Therapy. 16(1). 294–294.
3.
Graça, Inês, Vera Miranda‐Gonçalves, Rui Henrique, et al.. (2021). Anti-neoplastic and demethylating activity of a newly synthetized flavanone-derived compound in Renal Cell Carcinoma cell lines. Biomedicine & Pharmacotherapy. 141. 111681–111681. 3 indexed citations
4.
Monteiro‐Reis, Sara, Ana Lameirinhas, Vera Miranda‐Gonçalves, et al.. (2020). Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion. Cancers. 12(5). 1066–1066. 23 indexed citations
5.
Monteiro‐Reis, Sara, Daniela Barros‐Silva, Joäo Carvalho, et al.. (2019). Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype. Cancer Cell International. 19(1). 112–112. 14 indexed citations
6.
Barros‐Silva, Daniela, Pedro Costa‐Pinheiro, Henrique O. Duarte, et al.. (2018). MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis. Cell Death and Disease. 9(2). 167–167. 46 indexed citations
7.
Carvalho, Joäo, Céline S. Gonçalves, Inês Graça, et al.. (2018). A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97. Clinical Epigenetics. 10(1). 40–40. 45 indexed citations
8.
Graça, Inês, et al.. (2018). Targeting DNA Methyltranferases in Urological Tumors. Frontiers in Pharmacology. 9. 366–366. 32 indexed citations
9.
Carvalho, Joäo, Inês Graça, Antonio Gómez, et al.. (2017). Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. Journal of Hematology & Oncology. 10(1). 43–43. 45 indexed citations
10.
Ribeiro, Nilza, et al.. (2017). Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold. Journal of Biomedical Materials Research Part A. 105(7). 2035–2046. 10 indexed citations
11.
Lobo, João, Adriana R. Rodrigues, Luís Antunes, et al.. (2017). High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(4). 161.e7–161.e17. 38 indexed citations
12.
Carvalho, Joäo, Lina Cekaite, Anita Sveen, et al.. (2016). Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Letters. 385. 150–159. 55 indexed citations
13.
Graça, Inês, et al.. (2016). Epigenetic modulators as therapeutic targets in prostate cancer. Clinical Epigenetics. 8(1). 98–98. 65 indexed citations
14.
Luís, Ana, Joäo Carvalho, Pedro Costa‐Pinheiro, et al.. (2016). Prognostic significance of MST1R dysregulation in renal cell tumors.. PubMed. 6(8). 1799–811. 2 indexed citations
15.
Bartosch, Carla, et al.. (2015). Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium. Oncotarget. 7(2). 1144–1154. 71 indexed citations
16.
Graça, Inês, Elsa Sousa, Tiago Baptista, et al.. (2014). Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells. Current Pharmaceutical Design. 20(11). 1803–1811. 50 indexed citations
17.
Sousa, Elsa, Inês Graça, Tiago Baptista, et al.. (2013). Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing. Epigenetics. 8(5). 548–558. 51 indexed citations
18.
Carvalho, Joäo, Susana Lisboa, Inês Graça, et al.. (2013). Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations. PLoS ONE. 8(3). e58206–e58206. 27 indexed citations
19.
Pinheiro, Ana, Inês Graça, Joaquina Silva, et al.. (2012). Pyruvate dehydrogenase complex: mRNA and protein expression patterns of E1α subunit genes in human spermatogenesis. Gene. 506(1). 173–178. 11 indexed citations
20.
Sá, Rosália, Inês Graça, Joaquina Silva, et al.. (2012). Quantitative Analysis of Cellular Proliferation and Differentiation of the Human Seminiferous Epithelium In Vitro. Reproductive Sciences. 19(10). 1063–1074. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongping Cui Breakdown of academic impact, for papers by Paola Sanese Breakdown of academic impact, for papers by Yan-qing Ding Breakdown of academic impact, for papers by Yeyang Xu Breakdown of academic impact, for papers by Yadong Sun Breakdown of academic impact, for papers by Chaoxia Zou Breakdown of academic impact, for papers by Can Tan
Rankless by CCL
2026